(Q45954508)

English

Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study.

scientific article published on 4 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer's disease and cerebrovascular disease: a pilot study. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Alzheimer's disease

0 references

cerebral blood flow

0 references

cerebrovascular disease

1 reference

based on heuristic

inferred from title

author name string

Hirofumi Sakurai

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Haruo Hanyu

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Tomohiko Sato

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Kazumasa Kume

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Kentaro Hirao

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Hidekazu Kanetaka

6

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Toshihiko Iwamoto

7

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

publication date

4 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Geriatrics and Gerontology International

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

13

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

90-97

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Contribution of vascular risk factors to the progression in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Vascular factors predict rate of progression in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Predictors of progression of cognitive decline in Alzheimer's disease: the role of vascular and sociodemographic factors

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Relationship of vascular risk to the progression of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Vascular risk factors and progression in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Brain infarction and the clinical expression of Alzheimer disease. The Nun Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Effect of a clinical stroke on the risk of dementia in a prospective cohort.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Potent effects of novel anti-platelet aggregatory cilostamide analogues on recombinant cyclic nucleotide phosphodiesterase isozyme activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

A new clinical scale for the staging of dementia.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

9/Geriatric Depression Scale (GDS)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

“Mini-mental state”

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Effects of cilostazol on cerebral blood flow, P300, and serum lipid levels in the chronic stage of cerebral infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Cilostazol protects against brain white matter damage and cognitive impairment in a rat model of chronic cerebral hypoperfusion

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Concurrent administration of cilostazol with donepezil effectively improves cognitive dysfunction with increased neuroprotection after chronic cerebral hypoperfusion in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Impaired phosphorylation of cyclic AMP response element binding protein in the hippocampus of dementia of the Alzheimer type

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Cilostazol prevents amyloid β peptide25‐35‐induced memory impairment and oxidative stress in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Systematic Review of the Diagnostic Accuracy of 99mTc-HMPAO-SPECT in Dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1447-0594.2012.00866.X

21 January 2018

Identifiers

10.1111/J.1447-0594.2012.00866.X

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/22672107

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45954508&oldid=1516079049"